(NEW YORK) -- In yet another setback in the decadeslong scientific quest for an HIV vaccine, a Johnson & Johnson HIV vaccine candidate failed to reduce the risk of infection in a clinical trial among women in southern Africa. The would-be vaccine uses the same... Read More.
Latest Local News
Nationwide, nearly 55 million people are expected to travel... Read More.
Tis the season, and it’s here. Kick it off... Read More.
The Snohomish County Medical Examiner Offices’s (SCMEO) staff announced... Read More.